Advertise on podcast: Trending Health

In this episode of Trending Health, we explore how the Inflation Reduction Act (IRA) is reshaping strategy across the life sciences industry. Mindy McGrath is joined by Inizio Ignite colleagues, Scott Briggs and Ethan Johnson, to discuss how manufacturers are responding to Medicare price negotiation, Part D redesign, and increasing pressures on pricing and access. The conversation highlights what has surprised leaders so far, how payer dynamics are evolving, and how companies are rethinking portfolio and lifecycle decisions in a more constrained market. As future negotiation rounds approach, the episode offers a clear view into where organizations are focusing—and what they should be preparing for next. Panel –Mindy McGrath, Scott Briggs, Ethan Johnson Recording & Editing – Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com.

The brain health economy is emerging as a critical focus across healthcare and policy both for treating serious neurological and mental health diseases and for increasing brain capital for society. In this episode, Inizio Ignite’s Varun Renjen sits down with George Vradenburg, Chairman of the Davos Alzheimer\’s Collaborative and Harris Eyre, Executive Director of the Global Brain Economy Initiative to explore why it’s evolving so rapidly and what it means for life sciences companies. From how the brain health economy is evolving at the global level with growing importance from the World Economic Forum, to CNS trends, and to the impact of initiatives like the Davos Alzheimer’s Collaborative and the Davos Brain House, our guests unpack key developments shaping this space. We also examine the role of public-private partnerships and how life sciences companies can better engage. Finally, we look ahead: what does an ideal brain health ecosystem look like—and how can we build it? Panel – Varun Renjen, George Vradenburg, Harris Eyre  Recording & Editing – Mike Liberto, Rachel Skonecki  For additional discussion, please contact us at TrendingHealth.com.

In this news episode of Trending Health, Mindy McGrath and Everly Petruzzelli break down the evolving regulatory landscape at the FDA and what it means for life sciences leaders. This episode covers: Staff changes to the FDA and approval pathway pilot programsRising scrutiny on trial design — especially in rare diseaseThe FDA’s firmer stance on compounded GLP-1s as shortages ease From regulatory unpredictability to access, pricing, and portfolio risk, we explore how life sciences leaders should adapt in a more dynamic regulatory environment.  For additional discussion and to see the sources referenced in this episode, check out TrendingHealth.com.  Panel – Mindy McGrath & Everly Petruzzelli  Recording & Editing – Mike Liberto & Rachel Skonecki   Source Links:  J&J\’s Tecvayli-Darzalex multiple myeloma combo takes home FDA\’s 3rd national priority nod  FDA slammed over rare disease drug decisions Disc\’s rare disease drug hit by FDA rejection FDA rejects Biohaven approval request for troriluzole, triggering cost cutting FDA reverses course, agrees to review Moderna’s flu vaccine FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters

As 2026 begins, pharma leaders are placing sharper bets earlier while navigating increasing pressure across pricing, access, and evidence. In this episode, Matt Riordan, Group President, Putnam, shares a candid, executive-level view of what leaders are prioritizing this year, where confidence is high, and where blind spots may limit impact. Drawing on real-world leadership conversations, the discussion explores how access and evidence expectations are shifting upstream and what it takes to pressure-test assumptions, align strategy earlier, and lead with greater clarity in 2026. Panel – Mindy McGrath, Matt Riordan   Recording & Editing – Mike Liberto, Rachel Skonecki  For additional discussion, please contact us at TrendingHealth.com.

As we kick off 2026, Mindy sits down with Inizio Ignite Global President, Remco op den Kelder, to discuss the industry forces shaping the year ahead for life sciences companies.    Panel – Mindy McGrath, Remco op den Kelder   Recording & Editing – Mike Liberto, Rachel Skonecki    For additional discussion, please contact us at TrendingHealth.com.

The rules of product launch are changing fast. Policy reform, payer pressure, AI adoption, and shifting system dynamics are redefining how life sciences companies prepare for market.  In this episode, Summer Atkinson sits down with Vynamic Health Industry Advisor Mindy McGrath to unpack the biggest forces impacting launches today—from accelerating decision-making to growing health system control—and how leading organizations are building agility, transparency, and value-driven strategies to stay ahead.  To learn more about how we can help your team navigate these changing landscapes, please reach out to [email protected] or [email protected]   Podcast Tags: life sciences, product launch, market access, payer strategy, AI Panel – Summer Atkinson, Mindy McGrath Research & Production – Summer Atkinson, Adrea Cope Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com.

In recent years, there has been renewed interest in psychedelic treatment for a variety of medical conditions ranging from depression to trauma, and even dementia, which has left countless people searching for real recovery. This exciting research is challenging the limits of what’s possible. Psychedelic compounds, once misunderstood or dismissed, are now being studied for their ability to promote neuroplasticity, neurogenesis, and reduction in inflammation.  In this episode of Trending Health, we’re joined by three individuals who are passionate about the growing clinical utility of psychedelic treatments. However, with these treatments, it is critical to think about how to put the patient in the middle and engaged with their treatment to help ensure optimal outcomes:  Varun Renjen, a partner at Inizio Putnam and a physician who has been supporting biopharma clients as a strategy consultant for the past 15 years; especially in neurological diseases; Steve Levine, Chief Patient Officer at Compass Pathways and board-certified psychiatrist who has spent his career working to improve people’s lives through creating access to innovation in mental health;  Daniel Carcillo, a former NHL hockey player who developed Traumatic Brain Injury (TBI) and depression from the sport who has been successfully treated with psychedelic therapy as a patient and is an advocate for access to psychedelic treatment for brain injury  Tags: healthcare, psychedelics, psilocybin, mushrooms, concussions, traumatic brain injuries, depression, mental health, medical affairs  Panel – Varun Renjen, Steve Levine, Daniel Carcillo  Recording & Editing – Mike Liberto  For additional discussion, please contact us at TrendingHealth.com.

The traditional path to patients is being rewritten. As affordability pressures rise and patient expectations shift, life sciences companies are rethinking the middle — moving beyond payers, providers, and pharmacies to create direct, digital pathways that meet patients where they are. In this episode, host Adrea Cope is joined by Colleen Ferlotti and Rupa Mehta to unpack the rapid rise of Direct-to-Patient (DTP) models: what’s fueling the shift, how leaders are navigating regulatory and operational complexity, and why success depends on designing with both discipline and empathy. To learn more about how we can help your team navigate these changing landscapes, please reach out to [email protected] Podcast Tags: healthcare, life sciences, life sciences marketing, direct to patient, patient centricity, digital health   Source Links:  Triangle Insights Group (August 2025). The Direct-to-Patient Channel in Pharma: A Practical Guide to Protect GTN, Expand Access, and Improve Patient Experience.  Panel – Adrea Cope, Colleen Ferlotti, Rupa Mehta  Research & Production – Adrea Cope, Colleen Ferlotti, Rupa Mehta, Peter Svalbe, Mike Zapiec  Recording & Editing – Mike Liberto  For additional discussion, please contact us at TrendingHealth.com.

As Gen Z steps into the healthcare workforce, they’re bringing new expectations for authenticity, technology, and purpose-driven brands. The old pharma playbook? Invisible to this generation. In this episode of Trending Health, host Adrea Cope sits down with Carolyn Frantz and Mindy McGrath to explore how life sciences marketers can evolve to engage the next generation of HCPs and patients — from short-form content and streaming-first strategies to redefining the pharma rep of the future. To learn more about how we can help your team navigate these changing landscapes, please reach out to [email protected] or [email protected] Podcast Tags: healthcare, life sciences, life sciences marketing, Gen Z, digital health, brand authenticity Source Links: Gen Z more likely to report mental health concernsGeneration X Faces Higher Cancer Rates Than Boomers: Study Panel – Adrea Cope, Carolyn Frantz, Mindy McGrath Research & Production – Adrea Cope, Carolyn Frantz, Hannah Yee, Mike Zapiec Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com.

With external shifts in regulatory uncertainty tied to the IRA, payer pressures, shifting Federal and state policies, and broader scrutiny around pricing, Life Science companies are transforming their operations to deliver better value, grow, and create meaningful impact in the future. In this last episode of the Strategic Transformation series, Mindy McGrath is joined by Karen Baldry and Andrew Sgarlato to discuss what’s driving strategic transformations, how life science companies are tackling this and key considerations for leaders embarking on this journey. To learn more about how we can help your team navigate these strategic decisions, reach out to [email protected] and [email protected].  Podcast Tags: healthcare, life sciences, healthcare strategy, health innovation, strategic transformation  Panel – Mindy McGrath, Karen Baldry, Andrew Sgarlato  Research & Production – Mindy McGrath, Karen Baldry, Andrew Sgarlato  Recording & Editing – Mike Liberto, Rachel Skonecki  For additional discussion, please contact us at TrendingHealth.com.

Between pharmacy closures, drug shortages, technological innovations, and workforce shortages, pharmacies are at a pivot point and must evolve to keep up with this changing environment. In this episode of the Strategic Transformation series, Mindy McGrath, Saurabh Raman, and Ryan Hummel explore how the Pharmacy Channel is reimagining the pharmacist’s role from prescription dispensers to trusted, longitudinal care partners.   To learn more about how we can help your team navigate these strategic decisions, reach out to [email protected] and [email protected]. Podcast Tags: healthcare, pharmacy, pharmacy channel, healthcare strategy, health innovation, strategic transformation  Source Links:  2024-2025 Pharmacy Trends Include Improved Drug Shortages, More Pharmacy Closures  Walgreens agrees to be acquired by private equity firm for almost $10 billion Combating the Post-Pandemic Pharmacy Workforce Shortage Honesty/Ethics in Professions CVS reaps benefits of improved pharmacy experience  Why consumer experience is clinically important in health care Walgreens’ Move to Go Private: 4 Key Takeaways CVS is expanding its MinuteClinics into primary care. Here\’s why Where Are Amazon, CVS and Walgreens Headed in Health Care?  Panel – Mindy McGrath, Saurabh Raman, Ryan Hummel   Research & Production – Saurabh Raman, Ryan Hummel, Everly Petruzzelli  Recording & Editing – Mike Liberto, Rachel Skonecki  For additional discussion, please contact us at TrendingHealth.com.

In a world of financial pressures, workforce challenges, and increased focus on the patient experience, health systems are continuing to assess their operations to improve efficiencies and grow through strategic transformation. In this episode of the Strategic Transformation series, Mindy McGrath, Saurabh Raman, and Ryan Hummel discuss how health systems can best optimize their operational systems through standardization and centralization to address some of these challenges and improve their patient and employee experience.  To learn more about how we can help your team navigate these strategic decisions, reach out to [email protected] and [email protected].   Podcast Tags: healthcare, health systems, healthcare strategy, health innovation, strategic transformation Source Links:  2025 Outlook: Hospital finances show signs of stability, but rising costs will be a major headwind Costs of Caring | AHA  Emergency Department Utilization (EDU) – NCQA Patients as Consumers: New Research Report Shows A New Era of Expectations in Healthcare To Improve Health Care, Focus on Fixing Systems — Not People  Panel – Mindy McGrath, Saurabh Raman, Ryan Hummel   Research & Production – Saurabh Raman, Ryan Hummel, Everly Petruzzelli  Recording & Editing – Mike Liberto, Rachel Skonecki  For additional discussion, please contact us at TrendingHealth.com.

In this Trending Health series, Vynamic team members will highlight how different sectors of the health industry are evolving to meet the demands of today’s ever-changing healthcare landscape through value creation and strategic transformations. In this episode, Mindy McGrath, Saurabh Raman, and Ryan Hummel dive into how payers are shifting from short-term cost cutting to long-term strategic transformation as a result of rising costs, policy upheaval, and evolving consumer demands. To learn more about how we can help your team navigate these strategic decisions, reach out to [email protected] and [email protected].  Podcast Tags: healthcare, health plan, healthcare strategy, health innovation, strategic transformation  Source Links: Medical cost trend: Behind the numbers 2025 UnitedHealth reports highest medical costs since COVID-19 pandemic’s start New Evernorth program to cap out-of-pocket costs for Wegovy, Zepbound at $200 Spending growth on GLP-1s outpaces specialty drugs: Evernorth study Elevance Health Reports First Quarter 2024 Results  Panel – Mindy McGrath, Saurabh Raman, Ryan Hummel  Research & Production – Julia Morrison, Saurabh Raman, Ryan Hummel, Everly Petruzzelli Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com.

The complexity of today’s product launch environment demands a smarter, more optimized approach when it comes to planning—artificial intelligence (AI) is a potential tool to help teams keep up with the demanding pace. In the final episode of the Product Launch Series, Everly is joined by Ashley Stanley & Matt O\’Dell to explore how GenAI is already being leveraged across the launch lifecycle — from content creation to competitive intelligence — and how teams can build AI fluency now to stay ahead of tomorrow’s launch challenges. To learn more about how we can help your team integrate or optimize AI tools into your next product launch, reach out to [email protected] and [email protected]. Podcast Tags: healthcare, life sciences, product launch, product launch trends, life sciences trends, artificial intelligence, generative artificial intelligence, AI, GenAI   Sources: NYU AI Architect Says Mastering GenAI Means Changing Our Behavior   Panel –Everly Petruzzelli, Ashley Stanley, Matt O\’Dell  Research & Production – Zara Ahmad, Adrea Cope, Everly Petruzzelli   Recording & Editing – Mike Liberto, Rachel Skonecki  For additional discussion, please contact us at TrendingHealth.com.

In this special episode of Trending Health, Mindy McGrath and Karen Baldry explore how recent changes across the U.S. federal health agencies and policies from the new administration are impacting the life sciences and biotech industry compounding with other pressures like the IRA, tariffs, and budget constraints. From launch delays at the FDA to supply chain strain and evolving patient access challenges, Mindy and Karen provide strategic considerations for commercial leaders as they navigate these shifts and uncertainties.   To learn more about how we can help your team with scenario planning and navigating these strategic decisions, reach out to . Check out our recent insights for more information: U.S. Federal Health Agency Layoffs Pose Strategic Risk and Disruption to Life Sciences & The Case for Strategic Transformation: An Executive Conversation with Vynamic’s Leaders    Podcast Tags: healthcare, life sciences, public health, life sciences trends, healthcare strategy, health innovation    Panel – Mindy McGrath, Karen Baldry  Research & Production – Mindy McGrath, Karen Baldry, Everly Petruzzelli  Recording & Editing – Mike Liberto, Rachel Skonecki